000 01497 a2200409 4500
005 20250513195159.0
264 0 _c19991130
008 199911s 0 0 eng d
022 _a0002-9270
024 7 _a10.1111/j.1572-0241.1999.03368.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShanahan, F
245 0 0 _aNeurokinin antagonism and chemotherapy-induced emesis.
_h[electronic resource]
260 _bThe American journal of gastroenterology
_cNov 1999
300 _a3368-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAcetals
_xtherapeutic use
650 0 4 _aAntiemetics
_xtherapeutic use
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aAprepitant
650 0 4 _aCisplatin
_xadverse effects
650 0 4 _aDexamethasone
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aGranisetron
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMorpholines
_xtherapeutic use
650 0 4 _aMulticenter Studies as Topic
650 0 4 _aNausea
_xprevention & control
650 0 4 _aNeurokinin-1 Receptor Antagonists
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aSubstance P
_xantagonists & inhibitors
650 0 4 _aVomiting
_xchemically induced
700 1 _aO'Sullivan, G C
773 0 _tThe American journal of gastroenterology
_gvol. 94
_gno. 11
_gp. 3368-9
856 4 0 _uhttps://doi.org/10.1111/j.1572-0241.1999.03368.x
_zAvailable from publisher's website
999 _c10523031
_d10523031